Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 12/07 03:16:28 am
8247.5 GBX   -1.38%
02:54aAstraZeneca to Work with Ionis on Eplontersen Drug
DJ
02:19aAstraZeneca, Ionis to Co-Develop Protein Misfolding Disorder Drug
MT
01:55aASTRAZENECA : Jefferies is now Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Daiichi Sankyo's Enhertu Reduces Breast Cancer Death In Late-Stage Study

09/20/2021 | 12:22am EST


ę MT Newswires 2021
All news about ASTRAZENECA PLC
02:54aAstraZeneca to Work with Ionis on Eplontersen Drug
DJ
02:19aAstraZeneca, Ionis to Co-Develop Protein Misfolding Disorder Drug
MT
01:55aASTRAZENECA : Jefferies is now Neutral
MD
12/06AstraZeneca, Pfizer-BioNTech's COVID-19 Jabs Work Well With Moderna Shot, UK Study Says
MT
12/06Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK stud..
RE
12/06Odyssey buys drugmaker BenevolentAI in Europe's biggest SPAC deal
RE
12/06Odyssey buys drugmaker BenevolentAI in Europe's biggest SPAC deal
RE
12/06Odyssey Acquisition, BenevolentAI Sign Biggest European SPAC Merger Deal Worth $1.7 Bil..
MT
12/06Novartis working on pan-coronavirus oral treatment, CEO says
RE
12/06LONDON STOCK EXCHANGE : Reports of milder Omicron symptoms reassure investors
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 926 M - -
Net income 2021 2 827 M - -
Net Debt 2021 25 337 M - -
P/E ratio 2021 36,6x
Yield 2021 2,54%
Capitalization 172 B 172 B -
EV / Sales 2021 5,49x
EV / Sales 2022 4,49x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 110,91 $
Average target price 137,71 $
Spread / Average Target 24,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC14.19%171 675
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
PFIZER, INC.44.09%288 950
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321